Akili Announces Results from Pilot Study Showing Treatment with Project EVO™ Improves Cognitive Control in Children with Sensory Processing Dysfunction and Attentional Deficits Active IngredientsApril 5, 2017
Akili and Pfizer Present Positive Data from Digital Biomarker Study to Detect Subtle Cognitive Changes in Healthy Subjects at Risk of Developing Alzheimer’s Disease Active IngredientsDecember 9, 2016
Akili Adds Amgen Ventures and M Ventures* to Series B Financing, Increasing Round to $42.4 Million Active IngredientsJuly 20, 2016
Akili Interactive Labs Opens Enrollment for Pivotal Trial of Novel ADHD Treatment Active IngredientsMay 6, 2016
Digital Medicine Company Akili Interactive Labs Raises $30.5 Million to Advance Product Development and Build Commercial Infrastructure Active IngredientsJanuary 22, 2016
This video game might be the future of ADHD and Alzheimer's treatment Active IngredientsOctober 24, 2014
Convergence & unconventionality: One venture firm’s philosophy on early-stage innovation Active IngredientsApril 3, 2014